11/8/2010

The FDA has approved Bristol-Myers Squibb and AstraZeneca's Kombiglyze XR as an adjunct therapy to exercise and diet for adults with Type 2 diabetes. The once-daily pill comprises metformin, a standard diabetes treatment, and the drugmakers' Onglyza.

Related Summaries